{"id":6778,"date":"2008-05-05T17:12:10","date_gmt":"2008-05-05T08:12:10","guid":{"rendered":"http:\/\/mus.brc.riken.jp:7301\/?page_id=6778"},"modified":"2022-07-08T13:20:28","modified_gmt":"2022-07-08T04:20:28","slug":"may_2005_mm","status":"publish","type":"page","link":"http:\/\/mus.brc.riken.jp\/ja\/mouse_of_month\/may_2005_mm","title":{"rendered":"A Model for Impaired Cytokine Secretion"},"content":{"rendered":"<table style=\"max-width:700px;\">\n<tbody>\n<tr>\n<td style=\"border: 0px; background-color: #ffffff; text-align: center; white-space: nowrap;\" rowspan=\"2\" valign=\"middle\"><img decoding=\"async\" src=\"\/ja\/wp-content\/uploads\/2013\/05\/brc_logo2.png\" alt=\"RIKEN BRC\" width=\"36px\" height=\"74px\"\/><\/td>\n<td style=\"border: 0px; background-color: #ffffff; text-align: center; valign=middle\"><a href=\"\/ja\/mouse_of_month#2005\" style=\"text-decoration: none;\"><span style=\"color:#0000ff; font-style: italic; font-family: Times New Roman; font-size: 25pt; line-height: 130%; font-weight: bold;\">May 2005 <\/span><br \/>\n<span style=\"color:#000000; font-style: italic; font-family: Times New Roman; font-size: 25pt; line-height: 130%; font-weight: bold;\">Mouse of the Month<\/span><\/a>\n   <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"max-width:700px;\">\n<tbody>\n<tr>\n<td style=\"background-color: #ffffff; border: 0px; text-align: center;\">\n    <span style=\"font-size: x-large; font-weight : bold; line-height: 130%;\">A Model for Impaired Cytokine Secretion<\/span><\/p>\n<h5 style=\"text-align:center;\">\n     Increased susceptibility to viral infection due to lowered INF \u03b1 \/ \u03b2 production<br \/>\n     Targeted mutation,\u00a0<i>Irf3<sup>tm1Ttg<\/sup><\/i>, Chr 7<br \/>\n     Gene Symbol:<i>Irf3<\/i>\u00a0(interferon regulatory factor 3)<br \/>\n     Human homolog:<b><a href=\"http:\/\/omim.org\/entry\/603734\" target=\"_blank\" rel=\"noopener noreferrer\">HR (OMIM603734)<\/a><\/b><br \/>\n     BRC No. 00858<br \/>\nStrain name:<b>IRF-3 KO (C57BL\/6J) \/ B6.129S6-\u00a0<i>Irf3<sup>tm1Ttg<\/sup><\/i><\/b><\/h5>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #ffffff; border: 0px; text-align: center;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-6780\" alt=\"mn050531_0101\" src=\"\/ja\/wp-content\/uploads\/2008\/05\/mn050531_0101.png\" width=\"275\" height=\"206\" srcset=\"http:\/\/mus.brc.riken.jp\/ja\/wp-content\/uploads\/2008\/05\/mn050531_0101.png 275w, http:\/\/mus.brc.riken.jp\/ja\/wp-content\/uploads\/2008\/05\/mn050531_0101-150x112.png 150w\" sizes=\"auto, (max-width: 275px) 100vw, 275px\" \/><\/td>\n<\/tr>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<table style=\"max-width:700px;\">\n<tbody>\n<tr>\n<td style=\"border: 5px; background-color: #ffffff; text-align: left; white-space: normal; text-indent: 1em;\" valign=\"top\">Research Application: Immunology and Inflammation Research, Cancer Research. The Irf3 deficient mice were created by replacing a 2.2 kb region of Irf3 containing a putative transcription initiation site and the coding N-terminal region of the DNA binding domain. The analysis of MEFs demonstrated loss of Irf3 protein. Homozygous null mice are more susceptible to viral infection such as encephalomyocarditis virus and exhibit lower serum interferon levels in response to viral infection, indicating incapability of the mutant to respond against viral infection. A series of Irfs-KO mice have been deposited by Dr. T Taniguchi to the\u00a0<a href=\"https:\/\/www.brc.riken.jp\/lab\/animal\/\">RIKEN BRC<\/a>. <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<table style=\"max-width:700px;\">\n<tbody>\n<tr>\n<td style=\"background-color: #ffffff; border: 0px; text-align: left;\" colspan=\"2\">\n   <b>BRC No.\u00a0<a href=\"https:\/\/brc.riken.jp\/mus\/RBRC00915\" target=\"_blank\" rel=\"noopener noreferrer\">00915<\/a>, IRF-9 KO (BALB\/c) C.Cg-\u00a0<i>Irf9<sup>tm1Ttg<\/sup><\/i><br \/>\n      BRC No.\u00a0<a href=\"https:\/\/brc.riken.jp\/mus\/RBRC00916\" target=\"_blank\" rel=\"noopener noreferrer\">00916<\/a>, IRF-9 KO (C57BL\/6J) \/ B6.CB-\u00a0<i>Irf9<sup>tm1Ttg<\/sup><\/i><br \/>\n      BRC No.\u00a0<a href=\"https:\/\/brc.riken.jp\/mus\/RBRC01420\" target=\"_blank\" rel=\"noopener noreferrer\">01420<\/a>, IRF-7 KO \/ B6.129P2-\u00a0<i>Irf7<sup>m1Ttg<\/sup><\/i><\/b>\n   <\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #ffffff; border: 0px; text-align: left;\">DEPOSITOR:<\/td>\n<td style=\"background-color: #ffffff; border: 0px; text-align: left;\">Dr. Tadatsugu Taniguchi<\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #ffffff; border: 0px; text-align: left;\">Reference:<\/td>\n<td style=\"background-color: #ffffff; border: 0px; text-align: left;\">Sato M. Immunity 13, 539-548, 2000.<br \/>\nHonda K et al. Nature 434, 772-777, 2005.<\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #ffffff; border: 0px; text-align: left;\">For further information:<\/td>\n<td style=\"background-color: #ffffff; border: 0px; text-align: left;\">URL\u00a0http:\/\/www.immunol.m.u-tokyo.ac.jp\/english<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>May 2005 Mouse of the Month A Model for Impaired Cytokine Secretion Increased susceptibility to viral infection due to lowered INF \u03b1 \/ \u03b2 production Targeted mutation,\u00a0Irf3tm1Ttg, Chr 7 Gene Symbol:Irf [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":198,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-6778","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages\/6778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/comments?post=6778"}],"version-history":[{"count":12,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages\/6778\/revisions"}],"predecessor-version":[{"id":19088,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages\/6778\/revisions\/19088"}],"up":[{"embeddable":true,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages\/198"}],"wp:attachment":[{"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/media?parent=6778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}